Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2022
Total Assets: $18.15B
Liabilities Breakdown FY2022
Total Liabilities: $4.24B
Asset Breakdown
Total Assets: $18.15B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.50B | 57.9% |
| Accounts Receivable | $1.44B | 7.9% |
| Inventory | $460.6M | 2.5% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $1.09B | 6.0% |
| Intangible Assets | $603.6M | 3.3% |
| Other Assets | $4.05B | 22.3% |
Liabilities Breakdown
Total Liabilities: $4.24B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $303.9M | 7.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.93B | 92.8% |